Yavuguruwe ku ya 10 Kamena 2022, ukurikije ibyifuzo by'agateganyo byavuguruwe.
Itsinda ry’impuguke za OMS (SAGE) ryatanze ibyifuzo by'agateganyo byo gukoresha urukingo rwa Sinopharm kurwanya COVID-19.Iyi ngingo itanga incamake y'ibyo byifuzo by'agateganyo;urashobora kubona inyandiko yuzuye yubuyobozi hano.
Dore ibyo ugomba kumenya.
Ninde ushobora gukingirwa?
Urukingo rufite umutekano kandi rufite akamaro kubantu bose bafite imyaka 18 nayirenga.Hubahirijwe igishushanyo mbonera cya OMS hamwe na OMS iha agaciro Urwego, abakuze, abashinzwe ubuzima n’abantu badafite ubudahangarwa bagomba gushyirwa imbere.
Urukingo rwa Sinopharm rushobora gutangwa kubantu barwaye COVID-19 kera.Ariko abantu barashobora guhitamo gutinza urukingo amezi 3 nyuma yo kwandura.
Abagore batwite n'abonsa bagomba gukingirwa?
Amakuru aboneka ku rukingo rwa COVID-19 Sinopharm ku bagore batwite ntahagije kugira ngo hamenyekane ingaruka z’inkingo cyangwa ingaruka ziterwa n’inkingo zitwite.Nyamara, uru rukingo ni urukingo rudakorwa hamwe na aduvant ikoreshwa mu zindi nkingo nyinshi zifite umwirondoro mwiza w’umutekano, harimo no ku bagore batwite.Imikorere y'urukingo rwa COVID-19 Sinopharm ku bagore batwite rero biteganijwe ko yagereranywa n'iyagaragaye ku bagore badatwite bafite imyaka imwe.
Mu gihe gito, OMS irasaba ko hakoreshwa urukingo rwa COVID-19 Sinopharm ku bagore batwite igihe inyungu zo gukingira umugore utwite zirenze ingaruka zishobora kubaho.Kugira ngo bafashe abagore batwite gukora iri suzuma, bagomba guhabwa amakuru ajyanye n'ingaruka za COVID-19 batwite;inyungu zishoboka zo gukingirwa murwego rwa epidemiologiya yaho;n'imbogamizi zigezweho zamakuru yumutekano ku bagore batwite.Ninde udasaba kwipimisha inda mbere yo gukingirwa.Ninde udasaba gutinda gutwita cyangwa gutekereza guhagarika gutwita kubera inkingo.
Biteganijwe ko inkingo ikora neza izasa n’abagore bonsa kimwe n’abandi bantu bakuru.OMS irasaba gukoresha urukingo rwa COVID-19 Sinopharm mu bagore bonsa kimwe no mu bandi bantu bakuru.Ninde udasaba guhagarika konsa nyuma yo gukingirwa.
Ninde urukingo rutemewe?
Abantu bafite amateka ya anaphylaxis mubice byose bigize urukingo ntibagomba kubifata.
Umuntu wese ufite ubushyuhe bwumubiri hejuru ya 38.5ºC agomba gusubika urukingo kugeza igihe atagifite umuriro.
Ni umutekano?
SAGE yasuzumye neza amakuru yerekeye ubuziranenge, umutekano n’ingirakamaro y’urukingo kandi isaba ko yakoreshwa ku bantu bafite imyaka 18 nayirenga.
Amakuru yumutekano agarukira kubantu barengeje imyaka 60 (kubera umubare muto w'abitabira ibizamini bya kliniki).Nubwo nta tandukaniro riri hagati y’umutekano w’urukingo ku bantu bakuze ugereranije n’amatsinda mato ashobora gutegurwa, ibihugu bitekereza gukoresha uru rukingo ku bantu barengeje imyaka 60 bigomba gukomeza gukurikirana umutekano.
Urukingo rufite akamaro kangana iki?
Ikigeragezo kinini cy’ibihugu byinshi Icyiciro cya 3 cyerekanye ko dosiye 2, zitangwa mugihe cyiminsi 21, zifite ingaruka za 79% zo kurwanya indwara ya SARS-CoV-2 yanduye nyuma yiminsi 14 cyangwa irenga nyuma yo kunywa kabiri.Gukingira inkingo birwanya ibitaro byari 79%.
Urubanza ntirwakozwe kandi rufite imbaraga zo kwerekana ingaruka nziza ku ndwara zikomeye ku bantu bafite ibibazo, batwite, cyangwa ku bantu bafite imyaka 60 no hejuru yayo.Abagore ntibari bahagarariwe mu rubanza.Igihe giciriritse cyo gukurikirana kiboneka mugihe cyo gusuzuma ibimenyetso cyari iminsi 112.
Ibindi bigeragezo bibiri bya efficacy birakomeje ariko amakuru ntaraboneka.
Nibihe bisabwa?
SAGE irasaba gukoresha urukingo rwa Sinopharm nka dosiye 2 (0,5 ml) yatanzwe muburyo budasanzwe.
SAGE irasaba ko icya gatatu, cyongeweho urukingo rwa Sinopharm rwahabwa abantu bafite imyaka 60 nayirenga murwego rwo kwagura urukurikirane rwibanze.Amakuru agezweho ntabwo yerekana ko hakenewe urugero rwinyongera kubantu bari munsi yimyaka 60.
SAGE irasaba ko abantu bakomeye kandi badafite ubudahangarwa bagomba guhabwa urukingo rw’inkingo.Ibi biterwa nuko iri tsinda ridakunze kwitabira bihagije gukingirwa nyuma yuruhererekane rusanzwe rw’inkingo kandi bakaba bafite ibyago byinshi byo kwandura indwara zikomeye za COVID-19.
OMS irasaba intera y'ibyumweru 3-4 hagati yumwanya wa mbere nuwa kabiri wurwego rwibanze.Niba igipimo cya kabiri gitanzwe mugihe kitarenze ibyumweru 3 nyuma yambere, ikinini ntigikenewe gusubirwamo.Niba imiyoborere yikinini cya kabiri itinze kurenza ibyumweru 4, igomba gutangwa mugihe cyambere gishoboka.Mugihe utanga urugero rwinyongera kugeza hejuru yimyaka 60, SAGE irasaba ko ibihugu bigomba kubanza intego yo kugabanya umubare wibipimo 2 muri abo baturage, hanyuma bigatanga ikinini cya gatatu, uhereye kumatsinda yubusaza.
Ese dose ya booster irasabwa kurukingo?
Igipimo cya booster gishobora gufatwa nyuma y'amezi 4 - 6 nyuma yo kurangiza urukingo rwibanze rwo gukingira, guhera ku matsinda menshi yo gukoresha-gukoresha, hakurikijwe igishushanyo mbonera cya OMS.
Ibyiza byo gukingira booster bizwi nyuma yibimenyetso byinshi byerekana ko urukingo rugenda rwangirika kurwanya SARS-CoV-2 yanduye kandi idafite ibimenyetso.
Hashobora gukoreshwa homologous (ibicuruzwa bitandukanye byinkingo kuri Sinopharm) cyangwa heterologous (dose ya booster ya Sinopharm).Ubushakashatsi bwakorewe muri Bahrein bwerekanye ko kongera ingufu za heterologique byatumye habaho ubudahangarwa bw'umubiri ugereranije no kongera abahuje ibitsina.
Uru rukingo rushobora 'kuvangwa no guhuzwa' nizindi nkingo?
SAGE yemera inshuro ebyiri zidafite urukingo rwa OUL EUL COVID-19 nkurukurikirane rwibanze rwuzuye.
Kugirango hamenyekane ubudahangarwa buringaniye cyangwa bwiza cyangwa urukingo rwaba urukingo rwa OMS EUL COVID-19 mRNA (Pfizer cyangwa Moderna) cyangwa inkingo za OMS EUL COVID-19 zanduye (AstraZeneca Vaxzevria / COVISHIELD cyangwa Janssen) zishobora gukoreshwa nkigipimo cya kabiri gikurikira ikurikira ikinini cyambere hamwe ninkingo ya Sinopharm biterwa nibicuruzwa biboneka.
Irinda kwandura no kwandura?
Kugeza ubu nta makuru afatika aboneka ajyanye n'ingaruka za Sinopharm ku kwanduza SARS-CoV-2, virusi itera indwara ya COVID-19.
Hagati aho, OMS yibutsa ko ari ngombwa gukomeza no gushimangira ingamba z’ubuzima rusange zikora: guhisha, gutandukanya umubiri, gukaraba intoki, guhumeka no gukorora isuku, kwirinda imbaga no guhumeka bihagije.
Cyakora kurwanya ubwoko bushya bwa virusi ya SARS-CoV-2?
SAGE kuri ubu irasaba gukoresha uru rukingo, nk'uko byemezwa na Roadmap ya OMS.
Mugihe amakuru mashya aboneka, Ninde uzavugurura ibyifuzo.Uru rukingo ntirurasuzumwa mu rwego rwo gukwirakwiza ibintu byinshi bihangayikishije.
Uru rukingo rugereranya rute nizindi nkingo zimaze gukoreshwa?
Ntidushobora kugereranya inkingo imbonankubone bitewe nuburyo butandukanye bwafashwe mugutegura ubushakashatsi bujyanye, ariko muri rusange, inkingo zose zageze ku rutonde rwa OMS zikoreshwa byihutirwa zifite akamaro kanini mukurinda indwara zikomeye n’ibitaro kubera COVID-19 .
Igihe cyo kohereza: Jun-15-2022